Women's Health
Bringing together industry experts, we partner with you on your journey to develop therapies that improve the lives of women through transformative clinical research.
Transformative clinical research in women's health
With a deep understanding of therapeutic areas specific to women’s health, our expertise spans a wide range of diseases such as treatments for breast, cervical and ovarian cancers, osteoporosis, contraceptives and more. We’ve supported a range of biotech clients across different clinical phases and indications with tailored services.
Our team is made up of clinicians and investigators who understand the culture, patients, physicians and trial sites, with extensive experience of starting and overseeing trials globally.
By taking ownership of the success of your treatment from early to late phase and commercialization, we work closely with you to help advance the care and treatment of women’s health conditions across a multitude of therapeutic areas.
Breast, cervical and ovarian cancers
From early phase development to dose escalation in phase 1- 11aa studies, safety signal detections and trend analysis to regulatory approval we have the clinical expertise, insight, and diligent patient-centric monitoring to support your oncology study, every step of the way.
Osteoporosis
Our team has the expertise and experience so support strategy, design, planning and execution of orthopedic device, drug and combination product clinical trials globally.
Contraceptives
We have clinical expertise and experience in supporting trials for contraceptives, offering guidance on the nuanced approaches to the required length of studies, tracking adverse events and biometrics data management that these trials rely on.
Shared knowledge is power
We are fully invested in the outcomes of your trials, providing the resources and expertise when and how you need them and sharing therapeutic area expertise and knowledge to help you make the best decisions.
Speak to a global expert
Get your treatment to the women who need it most with the help of our clinical research experts with the right knowledge and experience in your unique therapeutic areas.
The latest from Caidya
Explore our news and updates as we liberate the clinical research process.
News
01/13/2025
Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders
News
07/22/2024
Caidya Announces Leadership Transition: Barbara Lopez Kunz Named CEO
News
06/12/2024